Поисковый запрос: (<.>S=ЯЗВА БУРУЛИ<.>) |
Общее количество найденных документов : 12
Показаны документы с 1 по 12
|
1.
| Wright Australia focuses on Mycobacterium ulcerans // Lancet, 1998. Vol. 351, N 9110.-С.1184
|
2.
| Lagarrigue L'ulcere de Buruli avec atteinte osseuse: A propos de de 33 cas au Benin // Med. trop.. -France, 2000. Vol. 60, N 2 прил..-С.70
|
3.
| Lagarrigue L'ulcere de Buruli avec atteinte osseuse: A propos de de 33 cas au Benin // Med. trop.. -France, 2000. Vol. 60, N 2 прил..-С.70
|
4.
| L'ulcere de buruli: Attention aux atteintes osseuses! A propos de 33 cas observes au Benin // Med. trop.. -France, 2000. Vol. 60, N 3.-С.262-266
|
5.
| Les atteintes osseuses dans l'Ulcere de Buruli. A propos de 73 cas // Bull. seances, 2003. Vol. 49, N 2.-С.161-190
|
6.
| Les atteintes osseuses dans l'Ulcere de Buruli. A propos de 73 cas // Bull. seances, 2003. Vol. 49, N 2.-С.161-190
|
7.
| Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer) // Clin. and Diagn. Lab. Immunol., 2002. Vol. 9, N 6.-С.1389-1391
|
8.
| Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans // Antimicrob. Agents and Chemother., 2005. Vol. 49, N 8.-С.3182-3186
|
9.
| Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans // Antimicrob. Agents and Chemother., 2005. Vol. 49, N 8.-С.3182-3186
|
10.
| Ultrasonography for the monitoring of subcutaneous damage in Mycobacterium ulcerans infection (Buruli Ulcer) // Ultrasound Med. and Biol., 2008. Vol. 34, N 10.-С.1554-1563
|
11.
| Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followdd by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease // Antimicrob. Agents and Chemother., 2014. Vol. 58, N 2.-С.1161-1166
|
12.
| Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followdd by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease // Antimicrob. Agents and Chemother., 2014. Vol. 58, N 2.-С.1161-1166
|
&uf('+1W2226#',v2226), ?>
|